1. Gastrointestinal hormones and gut motility
   Theo L. Peeters, 2015, Current Opinion in Endocrinology & Diabetes and Obesity CrossRef
2. Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome
   Mahanand Chatoo et al, 2018, Frontiers in Endocrinology CrossRef
3. Risk factors for irritable bowel syndrome: A review
   Olga V. Gaus et al, 2024, Terapevticheskii arkhiv CrossRef
4. Preclinical models of irritable bowel syndrome
   Laura López-Gómez et al, 2020, A Comprehensive Overview of Irritable Bowel Syndrome CrossRef
5. Proteomics and irritable bowel syndrome
   Athanasios Tsigaridas et al, 2017, Expert Review of Proteomics CrossRef
6. Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants
   Jessica M. Lee et al, 2018, Journal of Lipid Research CrossRef
7. Bile acid malabsorption is associated with diarrhea in acute phase of colitis
   Rui-gang Hou et al, 2018, Canadian Journal of Physiology and Pharmacology CrossRef
8. Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility
   Mengdi Jia et al, 2018, Journal of Neurogastroenterology and Motility CrossRef
9. Physical activity in relation to irritable bowel syndrome among Iranian adults
   Mehdi Sadeghian et al, 2018, PLOS ONE CrossRef
10. Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome
    Zheng-Yang Li et al, 2024, World Journal of Gastroenterology CrossRef
11. PI 3‐kinase‐ and ERK‐MAPK‐dependent mechanisms underlie Glucagon‐Like Peptide‐1‐mediated activation of Sprague Dawley colonic myenteric neurons
    Rebecca O'Brien et al, 2019, Neurogastroenterology & Motility CrossRef
12. Colorectal sensation and motility
    Vineet S. Gudsoorkar et al, 2014, Current Opinion in Gastroenterology CrossRef
13. Endocrine regulation of gut function – a role for glucagon‐like peptide‐1 in the pathophysiology of irritable bowel syndrome
    Dervla O'Malley, 2019, Experimental Physiology CrossRef
14. Early life adverse exposures in irritable bowel syndrome: new insights and opportunities
    Guo Qiong Zhou et al, 2023, Frontiers in Pediatrics CrossRef
15. The Glucagon‐like peptide‐1 receptor agonist, exendin‐4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome
    Rebecca O’Brien et al, 2020, Neurogastroenterology & Motility CrossRef
16. Glucagon‑like peptide‑1 analogue exendin‑4 modulates serotonin transporter expression in intestinal epithelial cells
    Xiufang Cui et al, 2020, Molecular Medicine Reports CrossRef